This Article Full Text Full Text (PDF) All Versions of this Article: 35/11_suppl_1/2659    most recent 01.STR.0000144051.32131.09v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Warach, S. Articles by Latour, L. L. Search for Related Content PubMed PubMed Citation Articles by Warach, S. Articles by Latour, L. L. Related Collections Acute coronary syndromes

(Stroke. 2004;35:2659.)
© 2004 American Heart Association, Inc.

Articles

Evidence of Reperfusion Injury, Exacerbated by Thrombolytic Therapy, in Human Focal Brain Ischemia Using a Novel Imaging Marker of Early Blood–Brain Barrier Disruption

From the National Institute of Neurological Disorders and Stroke, Bethesda, Md.

Correspondence to Dr Steven Warach, National Institute of Neurological Disorders & Stroke, 10 Center Drive, MSC 1063, Building 10, Room B1D733, Bethesda, MD 20892-1063. E-mail warachs{at}ninds.nih.gov

Loss of integrity of the blood–brain barrier (BBB) resulting from ischemia and reperfusion is a hypothesized precursor to hemorrhagic transformation (HT) and worse clinical outcome than would be expected from the beneficial effects of reperfusion. We used a novel magnetic resonance imaging marker to characterize early BBB disruption in acute focal brain ischemia and tested associations with reperfusion, HT, and poor outcome (modified Rankin score >2). The BBB disruption was evident as delayed gadolinium enhancement of cerebrospinal fluid space on fluid-attenuated inversion recovery (FLAIR) images and, for convenience, has been termed hyperintense acute reperfusion marker (HARM). HARM was found in 47 of 144 (33%) ischemic stroke patients. Reperfusion was found to be the strongest independent predictor of early BBB disruption (P=0.018) in multivariate analysis. HARM was associated with HT and worse clinical outcome (after adjustment for initial severity). It was also associated with more severe strokes at onset and greater age. Because the timing of the disruption was early enough (median estimate 3.8 hours from onset) to make it relevant to acute thrombolytic therapy, early BBB disruption as defined by HARM may be a promising target for adjunctive therapy to reduce the complications associated with thrombolytic therapy, broaden the therapeutic window, and improve clinical outcome.

Key Words: acute care • blood–brain barrier • stroke, hemorrhagic

This article has been cited by other articles:

				B R Thanvi, S Treadwell, and T Robinson Haemorrhagic transformation in acute ischaemic stroke following thrombolysis therapy: classification, pathogenesis and risk factors Postgrad. Med. J., July 1, 2008; 84(993): 361 - 367. [Abstract] [Full Text] [PDF]